Extranodal Lymphoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2022-04-07
Clinical Trial Update: Camrelizumab Plus R-CHOP Regimen in Untreated Primary Extranodal DLBCL [Phase 2]
Phase 2 trial evaluating camrelizumab plus R-CHOP in untreated primary extranodal diffuse large B-cell lymphoma (DLBCL).